My point is they have done an almost identical test and got almost identical results to their other great study which is still not usable. They have created a group of antibodies that bind to BARD1 proteins and fragments because it appears to be a tumor suppressor.
Lungs or ovaries doesn't matter too much but there is minor differences. If they haven't fixed the issue with the lung test then it isn't going to work with ovary test either.
Ann: Results of BARD1 Ovarian Cancer Study, page-30
-
- There are more pages in this discussion • 123 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.0¢ |
Change
0.015(3.09%) |
Mkt cap ! $55.76M | |||
| Open | High | Low | Value | Volume |
| 47.5¢ | 50.0¢ | 47.5¢ | $47.43K | 97.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 107495 | 48.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 7361 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |